Effects of nebulized ketamine on allergen-induced airway hyperresponsiveness and inflammation in actively sensitized Brown-Norway rats
Min Min Zhu, Qin Hai Zhou, Mei Hua Zhu, Hai Bo Rong, Yu Ming Xu, Yan Ning Qian, Cheng Zhang Fu, Min Min Zhu, Qin Hai Zhou, Mei Hua Zhu, Hai Bo Rong, Yu Ming Xu, Yan Ning Qian, Cheng Zhang Fu
Abstract
Since airway hyperresponsiveness (AHR) and allergic inflammatory changes are regarded as the primary manifestations of asthma, the main goals of asthma treatment are to decrease inflammation and maximize bronchodilation. These goals can be achieved with aerosol therapy. Intravenous administration of the anesthetic, ketamine, has been shown to trigger bronchial smooth muscle relaxation. Furthermore, increasing evidence suggests that the anti-inflammatory properties of ketamine may protect against lung injury. However, ketamine inhalation might yield the same or better results at higher airway and lower ketamine plasma concentrations for the treatment of asthma. Here, we studied the effect of ketamine inhalation on bronchial hyperresponsiveness and airway inflammation in a Brown-Norway rat model of ovalbumin (OVA)-induced allergic asthma. Animals were actively sensitized by subcutaneous injection of OVA and challenged by repeated intermittent (thrice weekly) exposure to aerosolized OVA for two weeks. Before challenge, the sensitized rats received inhalation of aerosol of phosphate-buffered saline (PBS) or aerosol of ketamine or injection of ketamine respectivity. Airway reactivity to acetylcholine (Ach) was measured in vivo, and various inflammatory markers, including Th2 cytokines in bronchoalveolar lavage fluid (BALF), as well as inducible nitric oxide synthase (iNOS) and nitric oxide (NO) in lungs were examined. Our results revealed that delivery of aerosolized ketamine using an ultrasonic nebulizer markedly suppressed allergen-mediated airway hyperreactivity, airway inflammation and airway inflammatory cell infiltration into the BALF, and significantly decreased the levels of interleukin-4 (IL-4) in the BALF and expression of iNOS and the concentration of NO in the inflamed airways from OVA-treated rats. These findings collectively indicate that nebulized ketamine attenuated many of the central components of inflammatory changes and AHR in OVA-provoked experimental asthma, potentially providing a new therapeutic approach against asthma.
Figures
References
- Iwata A, Nishio K, Winn RK, Chi EY, Henderson WR, Harlan JM. A Broad-Spectrum Caspase Inhibitor Attenuates Allergic Airway Inflammation in Murine Asthma Model. J Immunol. 2003;170:3386–3391.
- Rodrigo GJ. Inhaled therapy for acute adult asthma. Curr Opin Allergy Clin Immunol. 2003;3:169–175. doi: 10.1097/00130832-200306000-00004.
- Dhand R. Aerosol therapy for asthma. Curr Opin Pulm Med. 2000;6:59–70. doi: 10.1097/00063198-200001000-00012.
- Whittaker LA, Lauren C. Recent Concepts in the Pathogenesis and Treatment of Asthma [Obstructive Airways Disease] Clin Pulm Med. 2002;9:135–144. doi: 10.1097/00045413-200205000-00001.
- Reich DL, Silvay G. Ketamine: an update on the first twenty-five years of clinical experience. Can J Anaesth. 1989;36:186–97.
- Youssef-Ahmed MZ, Silver P, Nimkoff L, Sagy M. Continuous infusion of ketamine in mechanically ventilated children with refractory bronchospasm. Intensive Care Med. 1996;22:972–976.
- Sarma VJ. Use of ketamine in acute severe asthma. Acta Anaesthesiol Scand. 1992;36:106–107.
- Heshmati F, Zeinali MB, Noroozinia H, Abbacivash R, Mahoori A. Use of ketamine in severe status asthmaticus in intensive care unit. Iran J Allergy Asthma Immunol. 2003;2:175–180.
- Leal Filho MB, Morandin RC, de Almeida AR, Cambiucci EC, Borges G, Gontijo JA, Metze K. Importance of anesthesia for the genesis of neurogenic pulmonary edema in spinal cord injury. Neurosci Lett. 2005;373:165–170. doi: 10.1016/j.neulet.2004.10.019.
- Neder MT, Lazaro DSA. Ketamine reduces mortality of severely burnt rats, when compared to midazolam plus fentanyl. Burns. 2004;30:425–430. doi: 10.1016/j.burns.2004.01.006.
- Sun J, Li F, Chen J, Xu J. Effect of ketamine on NF-kappa B activity and TNF-alpha production in endotoxin-treated rats. Ann Clin Lab Sci. 2004;34:181–186.
- Helmer KS, Cui Y, Dewan A, Mercer DW. Ketamine/xylazine attenuates LPS-induced iNOS expression in various rat tissues. J Surg Res. 2003;112:70–8. doi: 10.1016/S0022-4804(03)00138-0.
- Lau TT, Zed PJ. Does ketamine have a role in managing severe exacerbation of asthma in adults? Pharmacotherapy. 2001;21:1100–1106. doi: 10.1592/phco.21.13.1100.34618.
- Lauretti GR, Lima Izabel CPR, Reis MP, Prado WA, Pereira NL. Oral Ketamine and Transdermal Nitroglycerin as Analgesic Adjuvants to Oral Morphine Therapy for Cancer Pain Management. Anesthesiology. 1999;90:1528–1533. doi: 10.1097/00000542-199906000-00005.
- Garcia-Velasco P, Roman J, de Beltran HB, Metje T, Villalonga A, Vilaplana J. Nasal ketamine compared with nasal midazolam in premedication in pediatrics. Rev Esp Anestesiol Reanim. 1998;45:122–125.
- Malinovsky JM, Servin F, Cozian A, Lepage JY, Pinaud M. Ketamine and norketamine plasma concentrations after iv., nasal and rectal administration in children. British Journal of Anaesthesia. 1996;77:203–207.
- Elwood W, Lotvall JO, Barnes PJ, Chung KF. Characterization of allergen-induced bronchial hyperresponsiveness and airway inflammation in actively sensitized brown-Norway rats. J Allergy Clin Immunol. 1991;88:951–960. doi: 10.1016/0091-6749(91)90253-K.
- Vanacker NJ, Palmans E, Kips JC, Pauwels RA. Fluticasone Inhibits But Does Not Reverse Allergen- Induced Structural Airway Changes. Am J Respir Crit Care Med. 2001;163:674–679.
- Xu KF, Vlahos R, Messina A, Bamford TL, Bertram JF, Stewart AG. Antigen-induced airway inflammation in the Brown Norway rat results in airway smooth muscle Hyperplasia. Journal of Applied Physiology. 2002;93:1833–1840.
- Stenton GR, Ulanova M, Déry RE, Merani S, Kim MK, Gilchrist M, Puttagunta L, Musat-Marcu S, James D, Schreiber AD, Befus AD. Inhibition of Allergic Inflammation in the Airways UsingAerosolized Antisense to Syk Kinase. J Immunol. 2002;169:1028–1036.
- Bolze S, Boulieu R. HPLC determination of ketamine, norketamine, and dehydronorketamine in plasma with a high-purity reversed-phase sorbent. Clinical Chemistry. 1998;44:560–564.
- Rock MJ, Rocha SR, Lerner M, Brackett D, Wilson MF. Effect on airway resistance of ketamine by aerosol in guinea pigs. Anesth Analg. 1989;68:506–510. doi: 10.1213/00000539-198904000-00015.
- Waserman S, Olivenstein R, Renzi PM, Xu LJ, Martin JG. The relationship between late asthmatic responses and antigen-specific immunoglobulin. J Allergy Clin Immunol. 1992;90:661–669. doi: 10.1016/0091-6749(92)90140-W.
- Bellofiore S, Martin JG. Antigen challenge of sensitised rats increases airway responsiveness to methacholine. J Appl Physiol. 1988;65:1642–1646.
- Kips JC, Cuvelier CA, Pauwels RA. Effect of acute and chronic antigen inhalation on airway morphology and responsiveness in actively sensitized rats. Am Rev Respir Dis. 1992;145:1306–1310.
- Palmans E, Kips JC, Puuwels RA. Prolonged allergen exposure induces structural airway changes in sensitized rats. Am J Respir Crit Care Med. 2000;161:627–635.
- Cockcroft DW. Airway Responsiveness. In: Barners PJ, Grunstein MM, Leff AR, Woolcock AJ, editor. Asthma. Lippincott-Raven Publishers, Philadelphia; 1997. pp. 1253–1265.
- Hodgson PE, Rehder K, Hatch DJ. Comparison of the pharmacodynamics of ketamine in the isolated neonatal and adult porcine airway. Br J Anaesth. 1995;75:71–79.
- Cheng EY, Mazzeo AJ, Bosnjak ZJ, Coon RL, Kampine JP. Direct relaxant effects of intravenous anesthetics on airway smooth muscle. Anesth Analg. 1996;83:162–168. doi: 10.1097/00000539-199607000-00028.
- Cortijo J, Blesa S, Martinez-Losa M, Mata M, Seda E, Santangelo F, Morcillo EJ. Effects of taurine on pulmonary responses to antigen in sensitized Brown-Norway rats. Eur J Pharmacol. 2001;431:111–117. doi: 10.1016/S0014-2999(01)01433-9.
- Inman MD, Ellis R, Wattie J, Denburg JA, O'Byrne PM. Allergen-induced increase in airway responsiveness, airway eosinophilia, and bone-marrow eosinophil progenitors in mice. Am J Respir Cell Mol Biol. 1999;21:473–479.
- Kay AB. The role of eosinophils in the pathogenesis of asthma. Trends Mol Med. 2005;11:148–52. doi: 10.1016/j.molmed.2005.02.002.
- Romagnani S. The role of lymphocytes in allergic disease. J Allergy Clin Immunol. 2000;105:399–408. doi: 10.1067/mai.2000.104575.
- Hamelmann E, Gelfand EW. IL-5-induced airway eosinophilia-the key to asthma? Immunological Reviews. 2001;179:182–191. doi: 10.1034/j.1600-065X.2001.790118.x.
- Kuperman DA, Huang XZ, Koth LL, Chang GH, Dolganov GM, Zho Z, Elias JA, Sheppard D, Erle DJ. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nature Medicine. 2002;8:885–889.
- Venkayya R, Lam M, Willkom M, Grunig G, Corry DB, Erle DJ. Th2 Lymphocyte products IL-4 and IL-13 rapidly induce Airway Hyperresponsiveness through direct effects on resident airway cells. Am J Respir Cell Mol Biol. 2002;26:202–208.
- Nakajima H, Sano H, Nishimura T, Yoshida S, Iwamoto I. Role of vascular cell adhesion molecule 1/very late activation antigen 4 and intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T cell recruitment into the tissue. J Exp Med. 1994;179:1145–1154. doi: 10.1084/jem.179.4.1145.
- Kawasaki T, Ogata M, Kawasaki C, Ogata J, Inoue Y, Shigematsu A. Ketamine suppresses proinflammatory cytokine production in human whole blood in vitro. Anesth Analg. 1999;89:665–669. doi: 10.1097/00000539-199909000-00024.
- Takenaka I, Ogata M, Koga K, Matsumoto T, Shigematsu A. Ketamine suppresses endotoxin- induced tumor necrosis factor alpha production in mice. Anesthesiology. 1994;80:402–408. doi: 10.1097/00000542-199402000-00020.
- Hill GE, Anderson JL, Lyden ER. Ketamine inhibits the proinflammatory cytokine-induced reduction of cardiac intracellular cAMP accumulation. Anesth Analg. 1998;87:1015–1019. doi: 10.1097/00000539-199811000-00006.
- Ricciardolo FLM. Multiple roles of nitric oxide in the airways. Thorax. 2003;58:175–182. doi: 10.1136/thorax.58.2.175.
- Hart CM. Nitric oxide in adult lung disease. Chest. 1999;115:1407–1417. doi: 10.1378/chest.115.5.1407.
- Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, Barnes PJ. Increased nitric oxide in exhaled air of asthmatic patients. Lancet. 1994;343:133–135. doi: 10.1016/S0140-6736(94)90931-8.
- Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329:2002–2012. doi: 10.1056/NEJM199312303292706.
- Shimaoka M, Iida T, Ohara A, Taenaka N, Mashimo T, Honda T, Yoshiya I. Ketamine inhibits nitric oxide production in mouse-activated macrophage-like cells. Br J Anaesth. 1996;77:238–242.
- Li CY, Chou TC, Wong CS, Ho ST, Wu CC, Yen MH, Ding YA. Ketamine inhibits nitric oxide synthase in lipopolysaccharide-treated rat alveolar macrophages. Can J Anaesth. 1997;44:989–995.
- Chang Y, Chen TL, Sheu JR, Chen RM. Suppressive effects of ketamine on macrophage functions. Toxicology and Applied Pharmacology. 2005;204:27–35. doi: 10.1016/j.taap.2004.08.011.
Source: PubMed